ALEXANDRIA, Va., Feb. 26 -- United States Patent no. 12,233,125, issued on Feb. 25, was assigned to The Johns Hopkins University (Baltimore).
"Method for treating pulmonary hypertension with antibodies to human Resistin" was invented by Roger A. Johns (Reisterstown, Md.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to the field of pulmonary, cardiac and inflammatory disorders. More specifically, the present invention provides methods and compositions for treating disorders associated with Resistin. In a specific embodiment, the present invention provides an antibody that binds human Resistin."
The patent was filed on Oct. 22, 2020, under Application No. 17/077,433.
*For furth...